Using routine healthcare data to evaluate the impact of the Medicines at Transitions Intervention (MaTI) on clinical outcomes of patients hospitalised with heart failure: protocol for the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial with embedded process evaluation, health economics evaluation and internal pilot

View/ Open
Powell_et_al_BMJ_Open (605.5Kb)
Download
Publication date
2022-04Author
Moreau, L.A.Holloway, I.
Fylan, Beth
Hartley, S.
Cundill, B.
Fergusson, A.
Alderson, S.
Alldred, David P.
Bojke, C.
Breen, Liz
Ismail, Hanif
Gardner, Peter H.
Mason, E.
Powell, Catherine
Silcock, Jonathan
Taylor, A.
Farrin, A.
Gale, C.
Keyword
Heart failureHeart failure medication
The Improving the Safety and Continuity Of Medicines management at Transitions (ISCOMAT) trial
Medicines at Transition Intervention (MaTI)
Healthcare data
Rights
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.Peer-Reviewed
YesOpen Access status
openAccess